Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn

µ-Slide Chamber

Photonics Spectra
Aug 2010
ibidi GmbHRequest Info
The μ-Slide Chemotaxis 3D, a chamber for chemotaxis and migration studies of nonadherent cells in 3-D gel matrices, has been released by ibidi GmbH. The slide enables motion tracking of lymphocytes, dendritic cells and macro-phages in gel matrices, including collagen. Previously, comparable cell-based assays allowed analysis of migrating cells only in 2-D. Now, the motility of nonadherent cells can be simulated, analyzed and quantified in an environment similar to in vivo over a 48-h period.


* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address 2:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required

When you click "Send Request", we will record and send your personal contact information to ibidi GmbH by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.
µ-Slide Chemotaxis 3D2D3D gel matricesassayBiophotonicscellschemotaxiscollagendendritic cellsgel matriceibidiibidi GmbHin vivolymphocytesMacrophagesmigrating cellsmigrationmotion trackingNew Productsnonadherent cellsslidethree-dimensional

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to Photonics Spectra magazine - FREE!
Are you interested in this product?
When you click "Send Request", we will send the contact details you supply to ibidi GmbH so they may respond to your inquiry directly.

Email Address:
Stop showing me this for the remainder of my visit
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.